Starting January 1, 2019, the Virginia Newborn Screening Program will start screening for Pompe disease and Mucopolysaccharidosis Type I (MPS I) . To view the informational webinar held on December 17, 2018, please visit:
In the News
Know your baby’s result! Knowing your baby’s newborn screening result can make a difference in his/her health.
The mission of the newborn screening program is to prevent intellectual disability, permanent disability, or death through early identification and treatment of infants who are affected by certain heritable disorders and genetic disease.
Need a dried blood spot screening result?
Call Division of Consolidated Lab Services (804) 648-4480 ext. 171
- Program consisting of education, dried-blood spot screening tests, follow-up and referral, diagnosis, medical and dietary management, and treatment.
- Makes it possible to find out whether newborn babies have disorders that may result in serious problems if treatment is not started soon after birth.
- Every newborn in Virginia is tested 24-48 after birth unless a parent or guardian objects on the grounds that the test conflicts with their religious practices.
- The Division of Consolidated Laboratory Services , Virginia Department of General Services, conducts the newborn dried blood spot screening tests in collaboration with VDH.
- VDH newborn screening nurses coordinate follow-up activities until the infant is diagnosed, screened negative, or reaches 6 months of age.
- Babies who are diagnosed with certain heritable disorders or genetic diseases through newborn blood-spot screening are referred to: Care Connection for Children for care coordination services.